Keyword: BioNTech


BioNTech to Acquire all of InstaDeep

16.01.2023 -

As it continues to leverage earnings from its top-selling mRNA-based Covid vaccine to deepen its existing knowhow, Mainz, Germany-based BioNtech has announced plans to...


BioNTech to Set up Oncology Base in Taiwan

20.12.2022 -

Germany’s BioNTech said it plans to accelerate and broaden the clinical development of its cancer immunotherapy pipeline in the Asia-Pacific region by expanding its...


Pfizer Files Rebuttal of Moderna’s Patent Claim

08.12.2022 -

Faced with a lawsuit from US rival Moderna, alleging that Pfizer and its German partner BioNTech infringed one of its patent for their top-selling Covid-19 vaccine...


BioNTech Buys Novartis Singapore Plant for Asia HQ

15.11.2022 -

German Covid-19 vaccine specialist BioNTech has acquired a production facility in Singapore from Swiss drugmaker Novartis that will serve as a manufacturing base in...


Pfizer/BioNTech Bivalent Covid Booster Wins Approvals

10.11.2022 -

UK health regulator Medicines and Healthcare products Regulatory Agency (MHRA) has approved the Pfizer/BioNTech bivalent Covid-19 vaccine for use as a booster in people...


Omicron-targeted Covid Boosters may not be Better

28.10.2022 -

The newly launched bivalent mRNA-based Covid-19 booster shots from Moderna and Pfizer/BioNTech did not show a major improvement over the companies’ first-generation...


EU Public Prosecutor Probes Vaccine Mega Order

20.10.2022 -

The European Public Prosecutors Office (EPPO) has confirmed that it is looking into the EU Commission’s ordering of Covid-19 vaccines, with the probe thought to pertain...


EMA’s CHMP Greenlights Omicron-1 Vaccines

06.09.2022 -

The human medicines committee (CHMP) of EU drug regulator European Medicines Agency (EMA) has recommended approval of the updated Covid-19 vaccines of Pfizer-BioNTech and...